CTSC:MGHresources:The Center for Biomarkers in Imaging

From NAMIC Wiki
Revision as of 19:24, 28 May 2009 by Valerie.humblet (talk | contribs) (→‎Contact)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Home < CTSC:MGHresources:The Center for Biomarkers in Imaging

Back to CTSC:MGHresources

The Center for Biomarkers in Imaging is an academic, non-profit organization dedicated to the identification, characterization and validation of biomarkers. Founded in April 2001, the Center is based within the Department of Radiology at the Massachusetts General Hospital. Located in downtown Boston, the hospital is a major teaching affiliate of Harvard Medical School. CBI has also joined forces with the Harvard-MIT Division of Health Sciences and Technology (HST), facilitating research collaborations and educational opportunities between CBI and HST, as well as the Harvard and MIT communities at large.

Mission/Vision

The Center for Biomarkers in Imaging (CBI) at MGH and HST is a non-profit, academic organization dedicated to the identification, characterization and validation of image-related biomarkers, defined as anatomic, physiologic, biochemical, or molecular parameters associated with the presence and severity of specific disease states. Built on extensive imaging experience, the Center for Biomarkers in Imaging will gather, catalog, and maintain an extensive, easily accessible database on biomarkers, to be shared with academia, government and industry. Through this process, CBI will promote the application of biomarkers as pre-clinical and clinical endpoints in the evaluation of new drugs and medical devices, ultimately resulting in more accurate, timely and transparent regulatory decisions.

Services

In addition to our web-based catalog of biomarkers, CBI provides a variety of services for the FDA, industry, and research. These include:

1) Biomarker validation for pre-clinical and clinical applications
2) Biomarker consulting
3) Clinical trial design
4) Confirmation of subject phenotype using biomarkers
5) Facilitation/conduct of clinical trials
6) Core laboratory services
7) Research portfolio assessment
8) Focused biomarker education

Contact

For additional information, visit the website or send an email.